Study identifier: NCT05677763 Synced from ClinicalTrials.gov · August 05, 2026
● Active Not Recruiting

OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness

Condition: Respiratory Tract Infections · Wheezing Lower Respiratory Illness  ·  Sponsor: OM Pharma SA

PhasePhase 4
Planned participants525
Who can joinAll sexes, 6 Months to 5 Years
Healthy volunteersNo

About this study

This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (42)

Ludwig Maximilians Universität MünchenMünchen, Bavaria, Germany
Clinical Research & Healthcare GmbHSchönau am Königssee, Bavaria, Germany
Medizinische Hochschule HannoverHanover, Lower Saxony, Germany
St. Josef-HospitalBochum, North Rhine-Westphalia, Germany
University Hospital Cologne AöRCologne, North Rhine-Westphalia, Germany
Ev. Krankenhaus DüsseldorfDüsseldorf, North Rhine-Westphalia, Germany
Praxis KöllgesMönchengladbach, North Rhine-Westphalia, Germany
Marien-Hospital Wesel gGmbHWesel, North Rhine-Westphalia, Germany
Universitätsklinikum Schleswig-Holstein Campus LübeckLübeck, Schleswig-Holstein, Germany
Aranyklinika KftSzeged, Csongrád megye, Hungary
Dr. Kenessey Albert Korhaz-RendelointezetBalassagyarmat, Hungary
Semmelweis Egyetem I.sz. Gyermekgyogyaszati KlinikaBudapest, Hungary

+ 30 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →